By inhibiting P‐gP, verapamil is capable of blocking many inflammatory mediating cytokines that contribute to the formation of nasal polyps (NP), including IL5, IL6 and thymic stromal lymphopoietin (TSLP), ultimately leading to TH2 production [6, 7]. This evidence concerns the gene TSLP and nasal cavity polyp.